Two regulatory domains are required for downregulation of c-myc transcription in differentiating U937 cells.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Oncogene

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8336940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

  1992cited by this paper
• myc function and regulation.

  1992cited by this paper
• MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.

  1992cited by this paper
• Cloning and characterization of a human c-myc promoter-binding protein

  1991cited by this paper
• A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.

  1990cited by this paper
• A FOS protein is present in a complex that binds a negative regulator of MYC.

  1989cited by this paper
• Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

  1989cited by this paper
• DNA replication origin and transcriptional enhancer in c‐myc gene share the c‐myc protein binding sequences.

  1989cited by this paper
• A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor

  1989cited by this paper
• fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene.

  1989cited by this paper
• E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

  1989cited by this paper
• An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c‐myc gene.

  1988cited by this paper
• Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene.

  1988cited by this paper
• Sequence requirements for premature termination of transcription in the human c-myc gene.

  1988cited by this paper
• Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells

  1988cited by this paper
• Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1

  1988cited by this paper
• Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate-promoted differentiation of leukemic cells.

  1987cited by this paper
• Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.

  1986cited by this paper
• Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment

  1986cited by this paper
• A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells

  1986cited by this paper
• The regulation and expression of c-myc in normal and malignant cells.

  1986cited by this paper
• Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation

  1986cited by this paper
• The myc oncogene: its role in transformation and differentiation.

  1986cited by this paper
• Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression.

  1986cited by this paper
• Evolution of tumours and the impact of molecular oncology

  1985cited by this paper
• Close link between reduction of c-myc expression by interferon and G0/G1 arrest

  1985cited by this paper
• The role of c-myc in the proliferation of normal and neoplastic cells

  1985cited by this paper
• Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma.

  1984cited by this paper
• Translocations among antibody genes in human cancer.

  1983cited by this paper
• The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma.

  1983cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper
• Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin.

  1981cited by this paper
• Natural killer cells kill tumour cells at a given stage of differentiation

  1981cited by this paper

• DNA Conformation Regulates Gene Expression: The MYC Promoter and Beyond

  2018cites this paper
• Telomeres in Aging: Birds

  2006cites this paper
• Differential expression of genes associated with telomere length homeostasis and oncogenesis in an avian model.

  2005cites this paper
• BLIMP-1: trigger for differentiation of myeloid lineage

  2000cites this paper
• An Element in the Region Responsible for Premature Termination of Transcription Mediates Repression of c-myc Gene Expression by Thyroid Hormone in Neuroblastoma Cells*

  2000cites this paper
• Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF*

  1999cites this paper
• Characterisation of the Myc negative autoregulation mechanism

  1997cites this paper
• Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells.

  1997cites this paper
• NM23/Nucleoside diphosphate kinase as a transcriptional activator of c-myc.

  1996cites this paper
• Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo

  1996cites this paper
• Attempts to Understand Metastasis Formation II

  1996cites this paper
• Transcription factors 2: helix-loop-helix.

  1995cites this paper
• A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

  1994cites this paper
• Transcription factors 2: helix-loop-helix.

  1994cites this paper